Occudo Quantitative Strategies LP Boosts Holdings in Tenet Healthcare Co. (NYSE:THC)

Occudo Quantitative Strategies LP increased its stake in Tenet Healthcare Co. (NYSE:THC - Free Report) by 174.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,933 shares of the company's stock after purchasing an additional 3,774 shares during the period. Occudo Quantitative Strategies LP's holdings in Tenet Healthcare were worth $749,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Meridiem Capital Partners LP purchased a new stake in Tenet Healthcare in the fourth quarter valued at $2,957,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Tenet Healthcare by 12.7% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,384 shares of the company's stock valued at $680,000 after acquiring an additional 608 shares in the last quarter. Moore Capital Management LP acquired a new stake in shares of Tenet Healthcare during the 4th quarter worth approximately $6,946,000. Lazard Asset Management LLC lifted its stake in shares of Tenet Healthcare by 745.9% in the 4th quarter. Lazard Asset Management LLC now owns 69,995 shares of the company's stock valued at $8,834,000 after purchasing an additional 61,720 shares during the period. Finally, Humankind Investments LLC grew its position in Tenet Healthcare by 6.5% during the fourth quarter. Humankind Investments LLC now owns 3,166 shares of the company's stock valued at $400,000 after buying an additional 194 shares during the period. Institutional investors and hedge funds own 95.44% of the company's stock.

Analyst Ratings Changes

THC has been the topic of a number of research analyst reports. Morgan Stanley lifted their price target on shares of Tenet Healthcare from $165.00 to $175.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. TD Cowen assumed coverage on Tenet Healthcare in a research note on Wednesday, February 26th. They set a "buy" rating and a $175.00 price objective for the company. Royal Bank of Canada lifted their price target on Tenet Healthcare from $183.00 to $189.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 30th. Bank of America raised their price objective on Tenet Healthcare from $165.00 to $180.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Finally, UBS Group increased their price objective on Tenet Healthcare from $217.00 to $230.00 and gave the stock a "buy" rating in a research report on Wednesday, April 30th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $174.94.

Insider Transactions at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 6,461 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $160.20, for a total transaction of $1,035,052.20. Following the sale, the executive vice president now owns 27,848 shares of the company's stock, valued at $4,461,249.60. This trade represents a 18.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the sale, the director now directly owns 27,378 shares in the company, valued at $3,434,022.54. This represents a 25.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,987 shares of company stock worth $2,972,421 over the last ninety days. 0.81% of the stock is currently owned by company insiders.

Tenet Healthcare Stock Up 0.9%

Shares of THC stock traded up $1.53 during trading hours on Monday, reaching $167.00. 1,296,753 shares of the stock were exchanged, compared to its average volume of 1,546,627. Tenet Healthcare Co. has a 12-month low of $109.82 and a 12-month high of $171.20. The business's fifty day moving average is $132.78 and its two-hundred day moving average is $136.16. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. The firm has a market capitalization of $15.51 billion, a P/E ratio of 5.18, a P/E/G ratio of 1.02 and a beta of 1.63.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.11 by $1.25. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The business had revenue of $5.22 billion for the quarter, compared to analyst estimates of $5.15 billion. During the same period last year, the firm posted $3.22 earnings per share. The company's revenue for the quarter was down 2.5% compared to the same quarter last year. As a group, research analysts expect that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.